🅇
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient.
Status
Recruiting
Phase
NA
NCT ID
NCT07452562
Trial Summary
This study is a randomised, double-blind, placebo-controlled trial investigating the effects of Hesperidin supplementation on cognitive function, fatigue, and stress.
Participants will be randomly assigned to receive either 500mg of Hesperidin or a matching placebo daily for 12 weeks. The primary outcome is fatigue, with secondary outcomes including cognitive performance and mood. The trial seeks to determine if this dietary intervention offers symptom-alleviating benefits.
Sponsor: Swansea University
Participants: ALL
Start: 2026-01-07
Completion: 2027-01-18
Min Age: 18 Years
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Multiple Sclerosis, Aged 18 years or older. Exclusion Criteria: * Known food allergies, intolerances, or significant gastrointestinal (GI) problems, Participants under the age of 18 years.
Data from ClinicalTrials.gov. Always verify on the primary source before clinical use.